Multi-country oncology trial starts vs Oncology novel active substance (NAS) launches (cumulative)
In 2015, multi-country oncology trial starts worldwide stood at 503, against 79 for oncology novel active substance (NAS) launches (cumulative).
Change the pair
Compare different indicators
The series
Over time
Global, spaced by time. Both series are in count,
so they share one axis; the legend names each line.
Multi-country oncology trial starts and Oncology novel active substance (NAS) launches (cumulative)
Unit: count · 6 observations
2 series · one axis View the underlying data
Shared periods
Side by side
Only one period is
published for both series. Comparing
anything else would mean comparing different years.
Provenance
Where these numbers come from
Absolute number of multi-country oncology trial starts in a given year.
3 observations in Global · source
organisations: IQVIA
Total number of oncology novel active substances launched over a stated multi-year period.
3 observations in Global · source
organisations: IQVIA
Data published under CC BY 4.0.
Series A as JSON · Series B as JSON